Lavakumar Karyampudi
Senior Director, Cell Therapies Moffitt Cancer Center
Seminars
Wednesday 16th September 2026
Evaluating Manufacturing to Balance Scientific Rigor & Commercial Scalability
2:05 pm
- Building robust, well-understood processes early to enable reliable and efficient scale-up
- Anticipating technical, cost, and operational constraints that may hinder translation from clinical manufacturing to commercial manufacturing
- Maintaining consistent, adaptable manufacturing and analytical systems from early trials to commercial production
